Sunrest Lifescience IPO Date, GMP, Review, Price, Form & Market Lot Details

The Sunrest Lifescience IPO has begun on 07-Nov-2023. It will close on 09-Nov-2023. The Total IPO Size is 10.85 Crores. The company set its IPO price is 84 Rs Per Share. Basically, There are two basic categories in Sunrest Lifescience IPO Subscription 1) Other 2) Retail Individual Investors (RIIs)

Sunrest Lifescience is established in 2017.

Sunrest Lifescience is offers a diverse range of healthcare and personal care products.

They deal in Capsules, Tablets, Syrup, Ointment, Gel, Mouth Wash, Solution, Suspension, Dry Powders and Toothpaste. Our product portfolio comprises of vide range of drugs like Anti-Bacterial, Anti Diarrheal, AntiFungal, Anti Malerial, Anti Diabetic, Dental Cure, Anti Protozol, Anti Histamine, Anti-Hypertensive drugs,
Cosmetic, Anti Parasitic, Multivitamin, Multimineral, Nutraceutical and Anti-inflammatory. The company have 18 Registered Trademarks for 32 products.

The Company is engaged in the marketing of OTC generic pharmaceutical products in the domestic market. The company offer range of pharmaceutical products manufactured by third party manufacturers. The company operate in different States of India such as Maharashtra, Gujarat, Madhya Pradesh, Orissa and Rajasthan.

Check :- Upcoming SME IPO 2023

Sunrest Lifescience IPO Promotor Holding

Mr. Nikhilkumar Y Thakkar, Mr. Amitbhai Shambhulal Thakkar, Mr. Bhagyesh Kiritbhai Parekh and Mr. Bharatkumar V Thakkar are the promoters of the company.

Sunrest Lifescience IPO Date, Details & Price Band

IPO Opening Dates 07-November-2023
IPO Closing Dates 09-November-2023
Price Band 84 Rs
Fresh issue 10.85 Crore
Total IPO size 10.85 Crore
Minimum bid (lot size) 1600 Shares
Face Value 10 INR Per Share
Listing On NSE SME

Sunrest Lifescience IPO Market Lot

The Sunrest Lifescience IPO minimum market lot is 1600 shares With 1,34,400 ₹ Amount per application.

Lot No of Shares Amount
Minimum 1 1600 1,34,400 Rs
Maximum 1 1600 1,34,400 Rs
S-HNI (Min) 2 3200 2,68,800 Rs

Restated Financial Record of the three year (Amt. in Lakhs)

Total Assets Total Revenue Profit After Tax
31-Mar-21 948.15 1,694.91 16.55
31-Mar-22 1,301.97 2,690.99 77.71
31-Mar-23 1,671.37 2,467.05 204.31

Sunrest Lifescience IPO GMP Grey Market Premium

Sunrest Lifescience IPO GMP Grey market premium has been started today. Check Latest Sunrest Lifescience IPO GMP Grey market premium, Kostak Rates and Subject to Sauda Price here.

Sunrest Lifescience IPO Prospectus

Sunrest Lifescience IPO
DRHP Download
RHP Download

Sunrest Lifescience IPO Reviews

AngelOne – Update Soon
Choice Broking – Update Soon
Prabhudas Lilladher – Update Soon

Sunrest Lifescience IPO Form Download

Sunrest Lifescience IPO is available on NSE Website as well as on our Portal. Please click here Sunrest Lifescience IPO form Download.

Sunrest Lifescience IPO Allotment Date & Details

Allotment Date 15-November-2023
Initiation of refunds 16-November-2023
Transfer of shares to Demat accounts 17-November-2023
Listing Date 20-November-2023
Check Allotment Status Click here

Registrar of Sunrest Lifescience IPO

Skyline Financial Services Private Limited
CIN – U74899DL1995PTC071324
D-153/ A, First Floor, Okhla Industrial Area,
Phase – I, New Delhi – 110020
Telephone – +91 1126812682
E-mail id: [email protected]
Investor Grievance Email: [email protected]
Contact person: Mr. Anuj Rana
Website: http://www.skylinerta.com/; SEBI Regn. No.: INR000003241

Sunrest Lifescience Contact Details

Sunrest Lifescience Limited
FF-41, Ajay Tenament-6,
Near Canal Near Ritanagar, Bus Stand Vastral Road,
Ahmedabad-382415
Phone: +91-079 – 29918245
Email: [email protected]
Website: https://sunrestlifescience.com/

Sunrest Lifescience IPO Lead Managers

Mark Corporate Advisors Private Limited
CIN – U67190MH2008PTC181996
404/1, The Summit Business Bay, Sant Janabai Road (Service Lane),
Off W. E. Highway, Vile Parle (East), Mumbai-400 057. Maharashtra, India
Tel. No.: +91 22 2612 3208
Email ID: [email protected]
Investor Grievance Email ID: [email protected]
Contact Person: Mr. Niraj Kothari
Website: www.markcorporateadvisors.com; SEBI Regn. No.: INM000012128